The Technical Analyst
Select Language :
Milestone Pharmaceuticals [MIST]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Milestone Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Milestone Pharmaceuticals is listed at the  Exchange

-0.56% $1.790

America/New_York / 28 mar 2024 @ 16:00


Milestone Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 95.14 mill
EPS: -1.390
P/E: -1.290
Earnings Date: May 09, 2024
SharesOutstanding: 53.15 mill
Avg Daily Volume: 0.364 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Strong Buy
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.290 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.22x
Company: PE -1.290 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-0.897
(-150.10%) $-2.69
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.603 - 1.977

( +/- 10.45%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-06-07 Wills Robert James Buy 30 000 Stock Option (right to buy)
2023-06-07 Tomsicek Michael John Buy 30 000 Stock Option (right to buy)
2023-06-07 Pasternak Richard C Buy 30 000 Stock Option (right to buy)
2023-06-07 Liebert Debra K. Buy 30 000 Stock Option (right to buy)
2023-06-07 Giles Lisa M. Buy 30 000 Stock Option (right to buy)
INSIDER POWER
3.02
Last 95 transactions
Buy: 18 033 611 | Sell: 4 881 578

Forecast: 16:00 - $1.760

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.760
Forecast 2: 16:00 - $1.760
Forecast 3: 16:00 - $1.760
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.790 (-0.56% )
Volume 0.454 mill
Avg. Vol. 0.364 mill
% of Avg. Vol 124.91 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Milestone Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Milestone Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Milestone Pharmaceuticals Inc

Last 10 Buy & Sell Signals For MIST

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Milestone Pharmaceuticals Inc

MIST

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Last 10 Buy Signals

Date Signal @
SSVUSDMar 28 - 15:5959.98
SNXUSDMar 28 - 16:00$4.88
ROUTEUSDMar 28 - 15:594.17
FORTHUSDMar 28 - 16:006.60
BCHUSDMar 28 - 16:00$570.06
SFPUSDMar 28 - 15:53$0.773
TAOUSDMar 28 - 15:54545.52
JAZZMar 28 - 15:55$120.49
CTXCUSDMar 28 - 15:54$0.485
GILDMar 28 - 15:54$73.31

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.